Drug Shortage Report for MED-BRIMONIDINE
| Report ID | 166353 |
| Drug Identification Number | 02507811 |
| Brand name | MED-BRIMONIDINE |
| Common or Proper name | Brimonidine 0.2% w/v 5 and 10 ml bottle |
| Company Name | GENERIC MEDICAL PARTNERS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BRIMONIDINE TARTRATE |
| Strength(s) | 0.2% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ml bottle and 10 ml bottle |
| ATC code | S01EA |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-08-01 |
| Actual start date | 2022-08-08 |
| Estimated end date | 2022-11-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-08-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-08-09 | English | Compare |
| v2 | 2022-08-08 | French | Compare |
| v1 | 2022-08-08 | English | Compare |
Showing 1 to 3 of 3